Current Report Filing (8-k)
22 Dezember 2022 - 9:01PM
Edgar (US Regulatory)
0000874710
false
0000874710
2022-12-19
2022-12-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
December 19, 2022
ALLIED HEALTHCARE
PRODUCTS, INC.
(Exact name of Company as specified in its charter)
Delaware |
0-19266 |
25-1370721 |
(State or Other Jurisdiction
of Incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
1720 Sublette Avenue, St. Louis,
Missouri
(Address of principal executive offices) |
63110
(Zip Code) |
Company’s telephone number, including area code |
(314) 771-2400 |
|
Not applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under
any of the following provisions:
| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the Company is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR §240.12b-2).
Emerging Growth Company ¨
If an emerging growth company, indicate by check mark if the Company
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b)
of the Act:
Title of Each Class |
Trading Symbol |
Name of Each Exchange on Which
Registered |
Common Stock, $.01 |
AHPI |
The NASDAQ Stock Market, LLC |
Item 2.05 Costs Associated with Exit or Disposal
Activities
Item 2.06 Material Impairments
On December 19, 2022, the Board of Directors of
Allied Healthcare Products, Inc. (the “Company”) approved a reduction in force that will impact employees of its St. Louis,
Missouri manufacturing facilities and certain employees of its administrative offices. Affected employees have been provided pre-termination
notices as required by the federal Worker Adjustment and Retraining Notification (“WARN”) Act and applicable state laws. The
reduction in force has been adopted in response to the Company’s ongoing losses from operations.
Workers will remain employed through the 60-day
WARN Act notice period, at which point the terminations will be effective. The Company does not expect to incur material severance obligations.
The reduction in force will result in the termination of substantially all of the Company’s union employees, which is expected to
trigger withdrawal liabilities owed to certain multiemployer pension plans which were recently estimated by such pension plans to be $17.5
million. The actual multiemployer plan withdrawal liability is not likely to be known until the conclusion of any and all appeal processes.
The Company expects that it will incur material
additional costs in association with actions that are contemplated pursuant to the reduction in force, which could include the impairment
of assets and professional fees. The Company is unable at this time to estimate the full amount of such charges and impairments. The Company
will file an amendment to this Form 8-K within four business days after it determines an estimate or range of estimates of these costs.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
ALLIED HEALTHCARE PRODUCTS, INC. |
|
|
|
By: |
Date: December 22, 2022 |
|
/s/ Daniel C. Dunn |
|
|
Daniel C. Dunn |
|
|
Chief Financial Officer |
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Allied Healthcare Products Inc (NASDAQ): 0 Nachrichtenartikel
Weitere Allied Healthcare Products Inc News-Artikel